Polyplus Concentrates Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 18-06-2024
- Paid Up Capital ₹ 0.20 M
as on 18-06-2024
- Company Age 15 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 5.43%
(FY 2023)
- Profit 95.23%
(FY 2023)
- Ebitda 43.25%
(FY 2023)
- Net Worth -0.01%
(FY 2023)
- Total Assets -19.57%
(FY 2023)
About Polyplus Concentrates
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Siddharth Somani and Gautam Somani serve as directors at the Company.
- CIN/LLPIN
U25209MH2009PTC189816
- Company No.
189816
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jan 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Polyplus Concentrates?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Siddharth Somani  | Director | 22-Jan-2009 | Current |
| Gautam Somani | Director | 22-Jan-2009 | Current |
Financial Performance of Polyplus Concentrates.
Polyplus Concentrates Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 5.43% increase. The company also saw a substantial improvement in profitability, with a 95.23% increase in profit. The company's net worth dipped by a decrease of 0.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Polyplus Concentrates?
In 2023, Polyplus Concentrates had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Guardian Healthcare Services Private LimitedActive 8 years 7 monthsGautam Somani is a mutual person
Everplus Plastics Private LimitedActive 22 years 4 monthsSiddharth Somani and Gautam Somani are mutual person
- Gopala Kraft Pack Private LimitedActive 29 years 11 months
Siddharth Somani and Gautam Somani are mutual person
- Kagaj Marketing And Trading Private LimitedActive 30 years 2 months
Siddharth Somani is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Polyplus Concentrates?
Unlock and access historical data on people associated with Polyplus Concentrates, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Polyplus Concentrates, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Polyplus Concentrates's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
